Best practice in primary care pathology: Review 6

Journal of Clinical Pathology

Volumn 60, Issue 3, 2007, Pages 225-234

  Smellie, W S A ^a   Forth, J ^b   Coleman, J J ^c   Irvine, W ^d   Dore, P C ^e   Handley, G ^f   Williams, D G ^g   Galloway, P J ^h   Kerr, K G ⁱ   Herriot, R ^j   Spickett, G P ^k   Reynolds, T M ^l  

^a BISHOP AUCKLAND GENERAL HOSPITAL   (United Kingdom)

^b Bede House   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e HULL ROYAL INFIRMARY   (United Kingdom)

^f QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^g SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^h ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

ⁱ HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^j ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^k ROYAL VICTORIA INFIRMARY   (United Kingdom)

^l QUEEN S HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; HEPARIN; HERPES ZOSTER IMMUNOGLOBULIN; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; RHEUMATOID FACTOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

ARTHRITIS; CHICKENPOX; CHRONIC DIARRHEA; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CREATININE BLOOD LEVEL; ELECTROLYTE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EVIDENCE BASED MEDICINE; FECES CULTURE; HEALTH CARE POLICY; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; KIDNEY FUNCTION; LABORATORY TEST; LOW DRUG DOSE; MEDICAL LITERATURE; MUMPS; NEPHELOMETRY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; SIDE EFFECT; VIRUS DETECTION;

ARTHRITIS; BIOLOGICAL MARKERS; CHICKENPOX; DIARRHEA; DRUG MONITORING; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MUMPS; PATHOLOGY, CLINICAL; PRIMARY HEALTH CARE;

EID: 33947375163     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.040014     Document Type: Review

References (91)

1. Joint Renal Association/Royal College Specialty Committee on Renal Disease. Chronic kidney disease in adults: UK guidelines for identification, management and referral. http://www.renal.org/CKDguide/full/UKCKDfull.pdf (accessed 5 Dec 2006).
2. Veterans Health Administration DoVA. The pharmacologic management of chronic heart failure. 2003. http://www.pbm.va.gov/guidelines/ 28766Chronicheartfailure.pdf.
3. Swedberg K, Cleland J, Dargie M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115- 40.
4. Task FM, Nieminen MS, Bohm M, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416.
5. Davies MK, Gibbs CR, Lip GYH. Management: diuretics, ACEI, and nitrates. In: Gibbs CR, Davies MK, Lip GYH, eds. ABC of heart failure. London: BMJ Books, 2000:25-8.
6. British Columbia Medical Association. British Columbia guidelines: heart failure care. 2003. http://www.healthservices.gov.bc.ca/msp/protoguides/ gps/heartfoilure.pdf.
7. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17.
8. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-51.
9. Department of Health UK. Coronary heart disease: national service framework for coronary heart disease - modem standards and service models. 2000. http://www.dh.gov.uk/assetRoot/04/05/75/26/04057526.pdf.
10. Scottish Intercollegiate Guidelines Network. Hypertension in older people. 2001. http://www.sign.ac.uk/pdf/sign49.pdf (accessed 5 Dec 2006).
11. Royal Infirmary of Edinburgh Renal Unit. How to start an ACEI. http://renux.dmed.ecf.ac.uk/EdREN/Unitbits/ACEIstart.html (accessed 5 Dec 2006).
12. Anon. Lowering blood pressure in particular patient groups. Drug Ther Bull 2001;39:37-40.
13. Williams B, Pouiter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85.
14. Bakris GL, Weir MR. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Intern Med 2000;160:685-93.
15. Prodigy. Prodigy guidance: hypertension. 2005. http://www.prodigy.nhs.uk/guidance.asp?gt=Hypertension (accessed 5 Dec 2006).
16. Baglin A, Boulard JC, Hanslik T, et al. Metabolic adverse reactions to diuretics. Clinical relevance to elderly patients. Drug Saf 1995; 12:161-7.
17. Joint National Committee. 7th report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure, http://www.nhlbi.nih.gov/guidelines/hypertension/express.pdf.
18. National Institute for Clinical Health and Excellence. CG5 Chronic heart failure: management of chronic heart failure in adults in primary and secondary carefull guideline. 2003. http://www.nice.org.uk/pdr/ Full_HF_Guideline.pdf (accessed 5 Dec 2006).
19. Eccles M, Freemanrle N, Mason J. North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure. BMJ 1998;316:1369-75.
20. McMurray J, Cohen-Solal A, Dietz R, et al. Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Fail 2001;3:495-502.
21. Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med 2002;347:1256-61.
22. Isles C. Cardiorenal failure: pathophysiology, recognition and treatment. Clin Med 2002;2:195-200.
23. Cowie MR, Hardman SM. Heart failure and angiotensin-converting enzyme inhibitors: towards evidence-based health care. Br J Hosp Med 1995;53:186-8.
24. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA 2003;289:2560-72.
25. Lopez-Sendon J, Swedberg K, McMurray J, for the Task Force on ACE inhibitors of the European Society of Cardiology, et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. Eur Heart J 2004;25:1454-70.
26. McMurray JJV, Ostergren J, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic lunction taking angiotensin-converting enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362:767-71.
27. Van Zeben D, Hazes JM, Zwinderman AH, et al. Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 1992;51:1029.
28. Shmerling RH, DelBanco TL. The rheumatoid factor: an analysis of clinical utility. Am J Med 1991;91:528.
29. Van Schaardenburg D, Hazes JM, de Boer A, et al. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. J Rheumatol 1993;20:45.
30. Arnett FC, Edworthy SM, Bloch DA, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315.
31. Bukhari M, Lunt M, Harrison BJ, et al. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis. Results from the Norfolk arthritis register study, a large inception cohort. Arthritis Rheum 2002;46:906.
32. Van der Heide A, Remme CA, Hofman DM, et al. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995;38:1466.
33. Mottonen T, Paimela L, Leirasalo-Repo M, et al. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis 1998;57:533.
34. Jonsson T, Valdimarsson H. Is measurement of rheumatoid factor isotypes clinically useful. Ann Rheum Dis 1993;52:161.
35. Wermick R, Merryman P, Jaffa I, et al. IgG and IgM rheumatoid factors in rheumatoid arthritis: quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum 1983;26:593.
36. Scott D, Dawes P, Collins M, et al. ELISA assays for IgM and IgG rheumatoid factors: their clinical correlations during therapy with slow-acting anti-rheumatic drugs. Clin Rheumatol 1987;6:358.
37. Mikuls TR, O'Dell JR, Stoner JA, et al. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody. Arth Rheum 2004;50:3776.
38. Anderson LG, Talal N. The spectrum of benign to malignant lymphoproliferation in Sjogren's syndrome. Clin Exp Immunol 1972;10:199-221.
39. Wener MH. Rheumatology laboratory tests 2005. American College of Rheumatology.
40. Hawkins BR, Dawkins RL, Christiansen FT, et al. Use of the B27 test in the diagnosis of ankylosing spondylitis: as statistical evaluation. Arthritis Rheum 1981;24:743-6.
41. Van der Linden, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-7.
42. Amor B, Dougados M, Mijiyawa M. Critere diagnostique des spondylarthropathies. Rev Rheum Mal Osteoartic 1990;57:85-9.
43. Shojania K. Rheumatology: 2. What laboratory tests are needed? Can Med Assoc J 2000;162:1157-69.
44. Baron M, Zendel I. HLA-B27 testing in ankylosing spondylitis: an analysis of the pretesting assumptions. J Rheumatol 1989;16:631-4.
45. Khan MA. Thoughts concerning the early diagnosis of ankylosing spondylitis and related diseases. Clin Exp Rheum, 2002;20(Suppl 28)S6-10.
46. Dougados M, Van der Linden S, Juhlin R, The European Spondyloarthropathy Study Group, et al. The European Spondyloasrthropathy study group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 1991;34:1218-27.
47. Calin A, Porta J, Fries JF, et al. Clinical history as a screening test for ankylosing spondylitis. J Am Med Assoc 1997;237:2613-14.
48. Gran JT. An epidemiological survey of the signs and symptoms of ankylosing spondylitis. Clin Rheumatol 1985;4:161-9.
49. Rudwaleit M, van der Heijde D, Khan MA, et al. How to diagnose axial spondylarthritis early. Ann Rheum Dis 2004;63:535- 43.
50. Sheehan NJ. The ramifications of HLA-B27. J R Soc Med 2004;97:10-4.
51. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis. Do we need new criteria. Arthritis Rheum 2005;52:1000-8.
52. Sieper J, Rudwaleit M. Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis 2005;64:659-63.
53. Underwood MR, Dawes P. Inflammatory back pain in primary care. Br J Rheumatol 1995;34:1074-7.
54. Prodigy Guidance. Ankylosing spondylitis. 2004. http://www.prodigy.nhs.uk/guidance.asp?gt=Ankylosing%20spondylitis (accessed 5 Dec 2006).
55. Talley NJ, O'Keefe EA, Zinsmeister AR, et al. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992;102:895-901.
56. Talley NJ, Weaver AL, Zinsmeister, AR, et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol 1992;136:167-77.
57. Thomas RD, Forbes A, Green J, et al. Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 2003;52:1-15.
58. Bertomeu A, Ros E, Barragán V, et al. Chronic diarrhoea with normal stool and colonic examinations: organic or functional? J Clin Gastroenterol 1991;13:531-6.
59. Isgar B, Harman M, Kaye MD, et al. Symptoms or irritable bowel syndrome in ulcerative colitis in remission. Gut 1983;24:190-2.
60. Thompson WG. Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease. Gut 1984;25:1089-92.
61. Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994;89:176-8.
62. Thompson D, Milford-Ward A, Whicher JT. The value of acute phase protein measurement in clinical practice. Ann Clin Biochem 1992;29:123-31.
63. Ackerman Z, Eliakim R, Stalnikowicz R, et al. Role of small bowel biopsy in the endoscopic evaluation of adults with iron deficiency anaemia. Am J Gastroenterol 1996;91:2099-102.
64. Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhoea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc 1993;68:691-702.
65. Bhutto ZA, Ghislan F, Undley K, et al. Persistent and chronic diarrhoea and malabsorption. Working party group report of the Second World Congress of Paediatric Gastro-enterology, Hepatology and Nutrition. J Paediatr Gastroent Nutr 2004;39:S711-16.
66. Carter L. What is the best way to evaluate and manage diarrhoea in the febrile infant? Clinical inquiries. J Fam Pract 2004;53:996- 9.
67. Cincinnati Children's Hospital Medical Centre. Evidence based clinical practice guideline for children with acute gastroenteritis (AGE). Cincinnati, OH: Cincinnati Children's Hospital Medical Centre, 2001, http://www.guideline.gov.
68. Armon K, Stephenson T, MacFaul R, et al. An evidence and consensus based guideline for acute diarrhoea management. Arch Dis Child 2001;85:132-42.
69. Knight CI, Sandhu BK. The investigation of chronic diarrhoea. Curr Paediatr 2003;13:89-94.
70. Thomas AG, Phillips AD, Walker-Smith JA. The value of proximal small intestinal biopsy in the differential diagnosis of chronic diarrhoea. Arch Dis Child 1992;67:741-4.
71. Walker-Smith JA, Guandalini S, Schmitz J, et al. Revised criteria for the diagnosis of Coeliac disease. Arch Dis Child 1990;65:909-11.
72. Puntis JWL. Assessment of pancreatic exocrine function. Arch Dis Child 1993;69:99-101.
73. Royal College of Obstetricians and Gynaecologists. Chickenpox in pregnancy. 2001. http://www.rcog.org.uk/resources/Public/pdf/Chickenpox_No13.pdf (accessed 5 Dec 2006).
74. Harger JH, Ernest JM, Thurnau GR, et al. Risk factors and outcome of varicellazoster virus pneumonia in pregnant women. J Infect Dis 2002;185:422-7.
75. Enders G, Miller E, Cradock-Watson J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548-51.
76. Chickenpox, pregnancy and the newborn. Drugs Ther Bull 2005;43:69-72.
77. Kudesia G, Partridge S, Farrington CP, et al. Changes in age-related seroprevalence of antibody to varicella-zoster virus: impact on vaccine strategy. J Clin Pathol 2002;55:154-5.
78. Nathwani D, Maclean A, Conway S, et al. Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998;36(Suppl 1):59-71.
79. Department of Health. Immunisation against infectious diseases. Varicella. 2006. http://www.dh.gov.uk/assetRoot/04/l 2/86/09/04128609.pdf.
80. Leinikki P. Mumps. In: Zuckerman AJ, ed. Principles and practice of clinical virology. 5th ed. New York: Wiley, 2004:459-66.
81. Guy RJ, Andrews RM, Kelly HA, et al. Mumps and rubella: a year of enhanced surveillance and laboratory testing. Epidemiol Infect 2004;132:391-8.
82. Health Protection Agency. Mumps notifications (confirmed cases England and Wales 1995-2005 by quarter). http://hpa.org.uk/infections/topics_az/ mumps/data_quarter.htm
83. Perry KR, Brown DW, Parry JV, et al. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 1993;40:235-40.
84. Smellie WSA, Wilson D, McNulty CAM, et al. Best practice in primary care pathology: review 1. J Clin Pathol 2005;58:1016-27.
85. Smellie WSA, Forth J, McNulty CAM, et al. Best practice in primary care pathology, review 2. J Clin Pathol 2006;59:113-20.
86. Smellie WSA, Forth J, Bareford D, et al. Best practice in primary care pathology: review 3. J Clin Pathol 2006;59:781-9.
87. Smellie WSA, Forth J, Sandar S, et al. Best practice in primary care pathology: review 4. J Clin Pathol 2006;59:893-902.
88. Smellie WSA, Forth J, Ryder S, et al. Best practice in primary care pathology: review 5. J Clin Pathol 2006;59:1229-37.
89. Smellie WSA, Wilson D, Finnigan DI, et al. Best practice in pathology. Methodology for constructing guidance. J Clin Pathol 2005;58:249-53.
90. General Medical Services Contract. www.nhsconfed.org/docs/ contract.pdf (accessed 5 Dec 2006).
91. Revisions to the GMS Contract 2006/7. http://www.nhsemployers.org/ primary/index.cfm (accessed 5 Dec 2006).